Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• BHB810

Snippet

Sponsor: BigHat Biosciences, Inc. | Conditions: Gastric Cancer, Gastric Adenocarcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING